Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biopharmx Corp (BPMX)

Biopharmx Corp (BPMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biopharmx Corp 115 Nicholson Lane San Jose CA 95134 USA

P: 650-889-5020

Description:

BioPharmX Corporation is a specialty pharmaceutical company. The company focuses on the development of novel drug delivery products for women's health, dermatology and otolaryngology markets. The Company's product pipeline includes products in categories consists of prescription products, over-the-counter products and dietary supplements. Prescription products in development include molecular iodine pill for the treatment of breast pain associated with fibrocystic breast disease. OTC product pipeline includes a series of medicated bandages, nasal sprays and other products. Supplement product pipeline includes BioPharmX's breast health pill. Its product candidates include BPX03 a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia and BPX01 a non-lipophilic topical antibiotic for the treatment of acne. BioPharmX Corporation is headquartered in Menlo Park, California.

Key Statistics

Overview:

Market Capitalization, $K 3,560
Shares Outstanding, K 10,480
Annual Sales, $ 60 K
Annual Net Income, $ -17,260 K
60-Month Beta -0.36
% of Insider Shareholders 3.40%
Float, K 10,124
% Float 96.60%

Growth:

1-Year Return -91.26%
3-Year Return -98.24%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/29/19
Earnings Per Share ttm -1.13
EPS Growth vs. Prev Qtr -52.00%
EPS Growth vs. Prev Year 24.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-25 on 04/26/19

BPMX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.67
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -827.58
Return-on-Assets (Before Tax) -317.70
Profit Margin % -28,766.67
Net Margin % N/A
Debt/Equity 0.67
Price/Sales 63.82
Price/Cash Flow N/A
Price/Book 2.55
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar